← Leaderboards
Mario Chojkier
Veterans Medical Research Fdn/San Diego
$9,606,602
Attributed
$12,946,977
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,946,977 · 10
VA$0 · 1
By mechanism
R44$3,901,921 · 3
R01$3,828,390 · 2
R37$3,405,276 · 1
R41$934,813 · 3
RC1$876,577 · 1
I01$0 · 1
Top collaborators
- Martina Buck10 shared
- Michael Norman Krupp4 shared
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationApoptosisGene ExpressionInjuryPreventLiverOxidative StressPeptidesReportingTransforming Growth FactorsClinical ResearchCellsCcaat-Enhancer-Binding ProteinsCell ProliferationChronicSiteInhibitor/AntagonistSignal TransductionCaspase-8Ccaat-Enhancer-Binding Protein-BetaLaboratory MousePlayFibrogenesisMutant
Grant awards (42)
An Agnostic, Host-Direct Survival Cure MCM for Pulmonary Toxicants.$999,601
R44 · FY2024 · AI
TREATMENT OF LUNG FIBROSIS : IND PHARMACOLOGY AND TOXICOLOGY$1,326,982
R44 · FY2020 · HL
TREATMENT OF LIVER INJURY AND FIBROSIS: SAFETY PHARMACOLOGY AND TOXICOLOGY$1,136,111
R44 · FY2020 · DK
TREATMENT OF LUNG FIBROSIS : IND PHARMACOLOGY AND TOXICOLOGY$224,967
R44 · FY2019 · HL
TREATMENT OF LIVER INJURY AND FIBROSIS: SAFETY PHARMACOLOGY AND TOXICOLOGY$214,260
R44 · FY2019 · DK
Targeting C/EBP-beta Phosphorylation for the Treatment of Lung Fibrosis$316,111
R41 · FY2015 · HL · contact PI
C/EBP-beta PEPTIDES FOR THE TREATMENT OF LUNG INJURY AND FIBROSIS$311,803
R41 · FY2014 · HL · contact PI
Liver Inflammation and Injury: Molecular Mechanisms$0
I01 · FY2014 · VA · contact PI
C/EBP-beta PEPTIDES FOR THE TREATMENT OF LIVER INJURY AND FIBROSIS$306,899
R41 · FY2013 · DK · contact PI
Liver Inflammation and Injury: Molecular Mechanisms$0
I01 · FY2013 · VA · contact PI
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$344,015
R37 · FY2012 · DK · contact PI
Liver Inflammation and Injury: Molecular Mechanisms$0
I01 · FY2012 · VA · contact PI
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$344,015
R37 · FY2011 · DK · contact PI
Liver Inflammation and Injury: Molecular Mechanisms$0
I01 · FY2011 · VA · contact PI
C/EBP beta Peptides for the Treatment of Hepatic Fibrosis$409,097
RC1 · FY2010 · DK
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$347,490
R37 · FY2010 · DK · contact PI
C/EBP beta Peptides for the Treatment of Hepatic Fibrosis$467,480
RC1 · FY2009 · DK
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$351,000
R37 · FY2009 · DK · contact PI
Hepatic Fibrosis: Molecular Mechanisms$315,322
R01 · FY2009 · DK · contact PI
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$40,150
R37 · FY2009 · DK · contact PI
Hepatic Fibrosis: Molecular Mechanisms$17,700
R01 · FY2009 · DK · contact PI
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$351,000
R37 · FY2008 · DK · contact PI
Hepatic Fibrosis: Molecular Mechanisms$315,322
R01 · FY2008 · DK · contact PI
Hepatic Fibrosis: Molecular Mechanisms$321,756
R01 · FY2007 · DK · contact PI
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$313,373
R37 · FY2007 · DK · contact PI
Hepatic Fibrosis: Molecular Mechanisms$331,366
R01 · FY2006 · DK · contact PI
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$322,733
R37 · FY2006 · DK · contact PI
Hepatic Fibrosis: Molecular Mechanisms$339,340
R01 · FY2005 · DK
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$330,500
R37 · FY2005 · DK
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$330,500
R37 · FY2004 · DK
C/EBP beta SIGNALS HEPATOCYTE PROLIFERATION AND SURVIVAL$330,500
R37 · FY2003 · DK
HEPATIC FIBROSIS: MOLECULAR MECHANISMS$265,682
R01 · FY2003 · DK
C/EBP BETA IN HEPATOCYTE GENE EXPRESSION &PROLIFERATION$306,358
R01 · FY2002 · DK
HEPATIC FIBROSIS: MOLECULAR MECHANISMS$257,942
R01 · FY2002 · DK
C/EBP BETA IN HEPATOCYTE GENE EXPRESSION &PROLIFERATION$297,436
R01 · FY2001 · DK
HEPATIC FIBROSIS: MOLECULAR MECHANISMS$250,429
R01 · FY2001 · DK
C/EBP BETA IN HEPATOCYTE GENE EXPRESSION &PROLIFERATION$72,324
R01 · FY2001 · DK
C/EBP BETA IN HEPATOCYTE GENE EXPRESSION &PROLIFERATION$288,774
R01 · FY2000 · DK
HEPATIC FIBROSIS: MOLECULAR MECHANISMS$243,134
R01 · FY2000 · DK
C/EBP BETA IN HEPATOCYTE GENE EXPRESSION &PROLIFERATION$120,372
R01 · FY2000 · DK
C/EBP BETA IN HEPATOCYTE GENE EXPRESSION &PROLIFERATION$50,152
R01 · FY2000 · DK
C/EBP BETA IN HEPATOCYTE GENE EXPRESSION &PROLIFERATION$34,981
R01 · FY2000 · DK